Success of tocilizumab in RA patients with remission induction and sustained efficacy after discontinuatio
Not Applicable
Completed
- Conditions
- rheumatoid arthritis
- Registration Number
- JPRN-UMIN000002744
- Lead Sponsor
- Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients whose Steinbrocker functional classification are class 4 2) Patients treated with leflunomide, disease modifying anti-rhuematic disease drugs without methotrexate, or tacrolimus 3) Patients who have ever treated with any of biologic agents 4) Patients treated with 10mg/day of predonisolone 5) Patients whose WBC is less than 4000 or lymphocytes is less than 1000 6) Patients with infection of HBV or EBV
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method